ClinicalTrials.govpublic full text
Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma
refractory plasma cell myeloma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 356475
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.